The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) announced that the name of the two organizations’ combined clinical research alliance will be the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The newly formed entity will conduct research focused on the full cancer care continuum.
“We are already actively engaged in the shared mission of reshaping the future of patient care through clinical research that leads to earlier cancer detection, more successful therapeutic intervention, greater rates of prevention and more successful patient outcomes,” said ACRIN Chair Mitchell D. Schnall, MD, PhD and ECOG Chair Robert L. Comis, MD, during a joint announcement at the 2011 ACRIN Annual Meeting. They said their two respective National Cancer Institute cooperative groups have merged their oncology research activities into three core areas of emphasis:
- Early detection and diagnosis of cancer;
- Biomarker-driven Phase II and Phase III therapeutic studies for multiple cancer types and stages; and
- Genetic, molecular and imaging marker research to predict and monitor treatment response.
The group also unveiled its logo and mission tagline: “Reshaping the future of patient care.”
Integration efforts have begun and the group’s leadership is developing the business, administrative and scientific framework for ECOG-ACRIN to sustain and streamline its combined research portfolio through public and private support.